Goldan Keith A. - Insider Non-Derivative Transactions at Syndax Pharmaceuticals Inc (SNDX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, Goldan Keith A.'s relationship to Syndax Pharmaceuticals Inc (SNDX) is Officer (Chief Financial Officer), and currently has 92,452 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SNDX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Goldan Keith A. - Insider Non-Derivative Transactions of SNDX Common Stock

Goldan Keith A. - Insider Non-Derivative Transactions at SNDX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	G -- (Common Stock)	1224	0	92452
Aug 1, 2025	J -- (Common Stock)	1226	8.43	93676
Jul 17, 2025	Sell -- (Common Stock)	1296	9.29	92450
May 20, 2025	P -- (Common Stock)	3000	0	93746
Feb 11, 2025	Sell -- (Common Stock)	3777	15.5	90746
Feb 6, 2025	Acquisition -- (Common Stock)	18500	0	71123
Feb 6, 2025	Acquisition -- (Common Stock)	23400	0	94523
Jun 15, 2024	P -- (Common Stock)	1250	20.03	52623
Feb 8, 2024	Acquisition -- (Common Stock)	35000	0	39673
Feb 8, 2024	Acquisition -- (Common Stock)	11700	0	51373
Feb 1, 2024	J -- (Common Stock)	1183	17.42	4673
Aug 1, 2023	J -- (Common Stock)	862	18.12	3490
Jun 14, 2023	Sell -- (Common Stock)	577	22.31	2628